prof. Sylvie Rottey

Journal Article

Heelkundige uitkomst na lymfeklierdissectie bij lokaal gevorderd renaal cel carcinoom: een retrospectieve analyse

Dries Vandendriessche, Victor Declerck, Simon Pauwelijn, Camille Berquin (UGent) , Pieter De Visschere (UGent) , Sofie Verbeke (UGent) , Sylvie Rottey (UGent) , Karel Decaestecker (UGent) , Nicolaas Lumen (UGent) and Charles Van Praet (UGent)

(2026) Tijdschrift voor Geneeskunde.

Add to list

Journal Article

The accuracy of PSMA PET/CT for assessing intraprostatic lesions in patients with prostate cancer: An evaluation of the PI-RADS, PRIMARY and PSMA-expression score

Eva Donck (UGent) , Pieter De Visschere (UGent) , Charles Van Praet (UGent) , Sofie Verbeke (UGent) , Sifrid Hendrickx (UGent) , Camille Berquin (UGent) , Sylvie Rottey (UGent) , Wesley Verla and Nicolaas Lumen (UGent)

(2025) Belgian Journal of Medical Oncology.

Add to list

Monitoring platinum-induced ototoxicity in adults : early and long-term audiovestibular outcomes

Heleen Van Der Biest (UGent) , Sarah Verhulst (UGent) , Hannah Keppler (UGent) , Eline Naert (UGent) , Sylvie Rottey (UGent) , Frederic Acke (UGent) and Ingeborg Dhooge (UGent)

(2025) B-Audio Congress 2025, Abstracts.

Add to list

Journal Article
A1
open access

Immune checkpoint-induced colitis : a single-center retrospective cohort study

Bengt Van Holder, Julie Vereecke (UGent) , Nathan Ureel, Triana Lobatón Ortega (UGent) , Anne Hoorens (UGent) , Amber Lievens, Marie Truyens (UGent) , Sylvie Rottey (UGent) , Karim Vermaelen (UGent) , Venita D'Cruz (UGent) , et al.

(2025) JOURNAL OF CLINICAL MEDICINE. 14(20).

Add to list

Conference Paper
C3
open access

Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Gabriële Holtappels (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Amber Meskens (UGent) , Sara Neyt (UGent) , et al.

(2025) 38th Annual Congress of the European Association of Nuclear Medicine - Abstracts. In EANM Innovation 1. p.s238-s239

Add to list

Journal Article
A1
open access

Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma : case study and literature review : an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need

Alexander Thooft (UGent) , Sofie Joris, Celine Jacobs (UGent) , David Creytens (UGent) , Sylvie Rottey (UGent) , Brigitte Maes, Philippe Aftimos and Lore Lapeire (UGent)

(2025) ACTA ONCOLOGICA. 64. p.1295-1306

Add to list

Early markers of sensorineural hearing loss after platinum-based chemotherapy

Heleen Van Der Biest (UGent) , Sarineh Keshishzadeh, Hannah Keppler (UGent) , Eline Naert (UGent) , Sylvie Rottey (UGent) , Ingeborg Dhooge (UGent) and Sarah Verhulst (UGent)

(2025) EAR AND HEARING.

Add to list

Journal Article
A1
open access

Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors : should we treat beyond two years?

Alexander Decruyenaere (UGent) , Christine Gennigens, Sylvie Rottey (UGent) , Annouschka Laenen, Emmanuel Seront, Els Everaert, Philip R Debruyne, Heidi Van Den Bulck, Julie Bastin, Annelies Verbiest, et al.

(2025) ACTA ONCOLOGICA. 64. p.979-988

Add to list

Conference Paper
C3
open access

Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Sara Neyt (UGent) , Sylvie Rottey (UGent) , Michael Saerens (UGent) , et al.

(2025) 11th European Congress on Head & Neck Oncology, Abstracts.

Add to list

A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer

Lissa Eggermont (UGent) , Nicolaas Lumen (UGent) , Charles Van Praet (UGent) , Joris Delanghe (UGent) , Sylvie Rottey (UGent) and Tijl Vermassen (UGent)

(2025) BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 1880(1).

Academic Bibliography

prof. Sylvie Rottey

Heelkundige uitkomst na lymfeklierdissectie bij lokaal gevorderd renaal cel carcinoom: een retrospectieve analyse

The accuracy of PSMA PET/CT for assessing intraprostatic lesions in patients with prostate cancer: An evaluation of the PI-RADS, PRIMARY and PSMA-expression score

Monitoring platinum-induced ototoxicity in adults : early and long-term audiovestibular outcomes

Immune checkpoint-induced colitis : a single-center retrospective cohort study

Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors

Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma : case study and literature review : an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need

Early markers of sensorineural hearing loss after platinum-based chemotherapy

Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors : should we treat beyond two years?

Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma

A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer

Contents

Support

Contact